[Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases]

Reumatol Clin. 2011 Sep-Oct;7(5):349-50. doi: 10.1016/j.reuma.2011.04.004. Epub 2011 Jun 30.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab
  • Adult
  • Aged
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / nursing
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / nursing
  • Humans
  • Injections, Subcutaneous
  • Middle Aged
  • Patient Preference
  • Self Administration
  • Surveys and Questionnaires

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab